Last reviewed · How we verify
Slit One — Competitive Intelligence Brief
phase 3
Biologic
Live · refreshed every 30 min
Target snapshot
Slit One (Slit One) — ASST Fatebenefratelli Sacco. Slit One is a drug that works by inhibiting the action of a specific protein.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Slit One TARGET | Slit One | ASST Fatebenefratelli Sacco | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). Slit One — Competitive Intelligence Brief. https://druglandscape.com/ci/slit-one. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab